Atrial fibrillation after cardiac surgery: Pathophysiology and treatment

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 8, Issue 3, 2004, Pages 175-183

  Palin, Christopher A ^a   Kailasam, Rajagopal ^a   Hogue Jr , Charles W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Campus Box 8054 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACECAINIDE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; ESMOLOL; FLECAINIDE; IBUTILIDE; INOTROPIC AGENT; INTERLEUKIN 6; MAGNESIUM; MESSENGER RNA; METOPROLOL; PLACEBO; POTASSIUM; PROCAINAMIDE; PROPAFENONE; SHORT ACTING DRUG; SOTALOL; UNINDEXED DRUG; VERAPAMIL;

AGING; ANOREXIA; ANTICOAGULANT THERAPY; BRADYCARDIA; BRONCHOSPASM; CARDIOVERSION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; FEVER; GASTROINTESTINAL SYMPTOM; GENETIC PREDISPOSITION; GENOTYPE; GLAUCOMA; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART ELECTROPHYSIOLOGY; HEART RATE; HEART SURGERY; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; HYPOTENSION; INTERNATIONAL STANDARD UNIT; LENGTH OF STAY; LIVER DYSFUNCTION; LUNG FIBROSIS; LUPUS ERYTHEMATOSUS; NAUSEA; NEUTROPENIA; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHLEBITIS; PHOTOSENSITIVITY; POLYNEUROPATHY; QT INTERVAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SINUS RHYTHM; STROKE; THROMBOEMBOLISM; THYROID DISEASE; TORSADE DES POINTES; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; URINE RETENTION; XEROSTOMIA;

ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; ELECTRIC COUNTERSHOCK; HUMANS; POSTOPERATIVE COMPLICATIONS;

EID: 4944220405     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/108925320400800302     Document Type: Conference Paper

References (62)

1. Falk RH: Atrial fibrillation. N Engl J Med 344:1067-1078, 2001.
2. Benjamin EJ, Levy D, Vaziri SM, et al: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840-844, 1994.
3. Sra J, Dhala A, Blanck Z, et al: Atrial fibrillation: epidemiology, mechanisms, and management. Curr Probl Cardiol 25:405-524, 2000.
4. Mathew JP, Fontes ML, Tudor IC, et al: A multicenter risk index for atrial fibrillation after cardiac surgery: JAMA 291:1720-1729, 2004.
5. Aranki SF, Shaw DP, Adams DH, et al: Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94:390-397, 1996.
6. Creswell LL, Schuessler RB, Rosenbloom M, et al: Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 56:539-549, 1993.
7. Lahey SJ, Campos CT, Jennings B, et al: Hospital readmission after cardiac surgery. Does "fast track" cardiac surgery result in cost saving or cost shifting? Circulation 98:35-40, 1998.
8. Zaman AG, Archbold RA, Helft G, et al: Atrial fibrillation after coronary artery bypass surgery: A model for preoperative risk stratification. Circulation 101:1403-1408, 2000.
9. Hogue CW Jr, Hyder ML: Atrial fibrillation after cardiac operation: Risks, mechanisms, and treatment. Ann Thorac Surg 69:300-306, 2000.
10. Stanley TO, Mackensen GB, Grocott HP, et al: The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 94:290-295, 2002.
11. Kim MH, Deeb GM, Morady F, et al: Effect of postoperative atrial fibrillation on length of stay after cardiac surgery. Am J Cardiol 87:881-885, 2001.
12. Allessie MA, Boyden PA, Camm AJ, et al: Pathophysiology and prevention of atrial fibrillation. Circulation 103:769-777, 2001.
13. Wijffels MC, Kirchhof CJ, Dorland R, et al: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954-1968, 1995.
14. Schotten U, Duytschaever M, Ausma J, et al: Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation 107:1433-1439, 2003.
15. Schotten U, Ausma J, Stellbrink C, et al: Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 103:691-698, 2001.
16. Yu WC, Lee SH, Tai CT, et al: Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 42:470-476, 1999.
17. Brundel BJ, Van Gelder IC, Henning RH, et al: Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 103:684-690, 2001.
18. Lai LP, Su MJ, Lin JL, et al: Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: An insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 33:1231-1237, 1999.
19. Carnes CA, Chung MK, Nakayama T, et al: Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89:32-38, 2001.
20. Gaudino M, Andreotti F, Zamparelli R, et al: The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 108:195-199, 2003.
21. Aviles RJ, Martin DO, Apperson-Hansen C, et al: Inflammation as a risk factor for atrial fibrillation. Circulation. 108:3006-3010, 2003.
22. Franz MR, Cima R, Wang D, et al: Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation 86:968-978, 1992.
23. Skubas NJ, Barzilai B, Hogue CW: Atrial fibrillation after coronary artery bypass graft surgery is unrelated to cardiac abnormalities detected by transesophageal echocardiography. Anesth Analg 93:14-19, 2001.
24. Shore-Lesserson L, Moskowitz D, Hametz C, et al: Use of intraoperative transesophageal echocardiography to predict atrial fibrillation after coronary artery bypass grafting. Anesthesiology 95:652-658, 2001.
25. Haissaguerre M, Jais P, Shah DC, et al: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659-666, 1998.
26. Tsai CF, Tai CT, Chen SA: Pulmonary vein ablation: Role in preventing atrial fibrillation. Curr Opin Cardiol 18:39-46, 2003.
27. Kalifa J, Jalife J, Zaitsev AV, et al: Intra-atrial pressure increases rate and organization of waves emanating from the Superior Pulmonary Veins During Atrial Fibrillation. Circulation 108:668-667, 2003.
28. Mullen JC, Khan N, Weisel, et al: Atrial activity during cardioplegia and postoperative arrhythmias. J Thorac Cardiovasc Surg 94:558-565, 1987.
29. Wu ZK, Iivainen T, Pehkonen E, et al: Fibrillation in patients subjected to coronary artery bypass grafting. J Thorac Cardiovasc Surg 126:1477-1482, 2003.
30. Archbold RA, Curzen NP: Off-pump coronary artery bypass graft surgery: The incidence of postoperative atrial fibrillation. Heart 89:1134-1137, 2003.
31. Ascione R, Caputo M, Calori G, et al: Predictors of atrial fibrillation after conventional and beating heart coronary surgery: A prospective, randomized study. Circulation 102:1530-1535, 2000.
32. van Dijk D, Nierich AP, Jansen EW, et al: Early outcome after off-pump versus on-pump coronary bypass surgery: Results from a randomized study. Circulation 104:1761-1766, 2001.
33. Salamon T, Michler RE, Knott KM, et al: Off-pump coronary artery bypass grafting does not decrease the incidence of atrial fibrillation. Ann Thorac Surg 75:505-507, 2003.
34. Place DG, Peragallo RA, Carroll J, et al: Postoperative atrial fibrillation: A comparison of off-pump coronary artery bypass surgery and conventional coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 16:144-148, 2002.
35. Kalman JM, Munawar M, Howes LG, et al: Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 60:1709-1715, 1995.
36. Jayachandran JV, Sih HJ, Winkle W, et al: Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation 101:1185-1191, 2000.
37. Herweg B, Dalal P, Nagy B, et al: Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. Am J Cardiol 82:869-874, 1998.
38. Hogue CW Jr, Domitrovich PP, Stein PK, et al: RR interval dynamics before atrial fibrillation in patients after coronary artery bypass graft. Circulation 98:429-434, 1998.
39. Liu L, Nattel S: Differing sympathetic and vagal effects on atrial fibrillation in dogs: Role of refractoriness heterogeneity. Am J Physiol 273:805-816, 1997.
40. Cummings JE, Gill I, Akhrass R, et al: Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fibrillation in humans. J Am Coll Cardiol 43:994-1000, 2004.
41. Fuster V, Ryden LE, Asinger RW, et al: American College of Cardiology/American Heart Association/European Society of Cardiology Board. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. J Am Coll Cardiol 38:1231-1266, 2001.
42. VanderLugt JT, Mattioni T, Denker S, et al: Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation 100:369-375, 1999.
43. Frost L, Mortensen PE, Tingleff J, et al: Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Int J Cardiol 58:135-140, 1997.
44. Wyse DG, Waldo AL, DiMarco JP, et al: Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-1833, 2002.
45. Carlsson J, Miketic S, Windeler J, et al: Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The strategies of treatment of atrial fibrillation (STAF) study. J Am Cardiol 41:1690-1696, 2003.
46. Echt DS, Liebson PR, Mitchell LB, et al: Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmias Suppression Trial. N Engl J Med 324:781-788, 1991.
47. Page RL, Kerber RE, Russell JK, et al: Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: The results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol 39:1956-1963, 2002.
48. Bechtel JF, Christiansen JF, Sievers HH, et al: Low-energy cardioversion versus medical treatment for the termination of atrial fibrillation after CABG. Ann Thorac Surg 75:1185-1188, 2003.
49. Hogue CW Jr, Murphy SF, Schechtman KB, et al: Risk factors for early or delayed stroke after cardiac surgery. Circulation 100:642-647, 1999.
50. van Walraven C, Hart RG, Singer DE, et al: Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. JAMA 288:2441-2448, 2002.
51. Troughton RW, Asher CR, Klein AL: The role of echocardiography in atrial fibrillation and cardioversion. Heart 89:1447-1454, 2003.
52. Rawles JM: What is meant by a "controlled" ventricular rate in atrial fibrillation? Br Heart J 63:157-161, 1990.
53. Moran JL, Gallagher J, Peake SL, et al: Parental magnesium sulphate versus amiodarone in the therapy of atrial tachyarrhythmias: A prospective, randomised study. Crit Care Med 23:1816-1824, 1995.
54. Hjelms E: Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment. Scand J Thorac Cardiovasc Surg 26:193-196, 1992.
55. Connolly SJ: Evidence-based analysis of amiodarone efficacy and safety. Circulation 100:2025-2034, 1999.
56. Larbuisson R, Venneman I, Stiels B: The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery. J Cardiothorac Vasc Anesth 10:229-234, 1996.
57. Di Biasi P, Scrofani R, Paje A, et al: Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. Eur J Cardiothorac Surg 9:587-591, 1995.
58. Murray KT: Ibutilide. Circulation 97:493-497, 1998.
59. Soucier R, Silverman D, Abordo M, et al: Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: Neither strategy improves outcomes compared to rate control alone (the PIPAF study). Med Sci Monit 9:19-23, 2003.
60. Singh S, Zoble RG, Yellen L, et al: Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: The symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 102:2385-2390, 2000.
61. Pedersen OD, Bagger H, Keller N, et al: Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: A Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation 104:292-296, 2001.
62. Pratt CM, Singh SN, Al-Khalidi HR, et al: The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction. J Am Coll Cardiol 43:1211-1216, 2004.